Chinese Journal of Tissue Engineering Research ›› 2011, Vol. 15 ›› Issue (24): 4519-4521.doi: 10.3969/j.issn.1673-8225.2011.24.037

Previous Articles     Next Articles

Marine algae polysaccharide derivant in treatment of osteoporosis in rats

Si Yan-li1, Li Dong-xia1, Liu You-cai2, Qian Zhi-bin1   

  1. 1Department of Functional Lab of Xinxiang Medical University, Xinxiang 453003, Henan Province, China
    2Sanquan College of Xinxiang Medical University, Xinxiang 453003, Henan Province, China
  • Received:2011-02-17 Revised:2011-05-13 Online:2011-06-11 Published:2011-06-11
  • About author:Si Yan-li, Assistant experimentalist, Department of Functional Lab of Xinxiang Medical University, Xinxiang 453003, Henan Province, China syl@xxmu.edu.cn

Abstract:

BACKGROUND: We have previously reported that marine algae polysaccharide derivant can significantly promote bone cell growth.
OBJECTIVE: To observe the effect of marin algae polysaccharide derivant in treatment of osteoporosis.
METHODS: Sixty female Wistar rats were randomly divided into control group, treatment group and model group. There were 20 rats in each group. The rats in treatment group and model group were respectively treated with retinoic acid to induce osteoporosis. The rats in treatment group were gavaged the marine algae polysaccharide derivant 10 mg/kg, and the rats in model group were gavaged the glucose 10 mg/kg orally for 14 days. Changes of rat femur bone histological examination and histomorphometry parameters were observed.
RESULTS AND CONCLUSION: The mean Trabecular Number (Tb.N), the mean Trabecular Thickness (Tb.Th) and the percent Trabecular Area (Tb.Ar%) were significantly decreased in the model group compared with control group. The mean trabecular separation (Tb.Sp) was greatly increased. After intake of marine algae polysaccharide derivant, Tb.N, Tb.Th and Tb.Ar% of the treatment group were significantly more than that of the model group. The Tb.Sp was obviously reduced. These indicate that marine algae polysaccharide derivant can increase bone mass and have a therapeutic and preventional effect on the osteoporosis.

CLC Number: